top of page

BCEL

Atreca Inc - Class A

$1.19

chg

-0.06 (-4.80%)

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

0.7595

52 wk hi

3.92

Cash

$117.9M

Burn Rate (Qtr)

$25.6M

Mkt Cap

$38.5m

Avg Volume

128,748

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

BCEL

BPIQ_Logo_RGB-01.jpg

Company Profile

We are a biopharmaceutical company developing novel therapeutics based on a deep understanding of the human immune response.

Recent Posts

See what the community is saying - click to see full post.

bottom of page